Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.
about
The life and times of the EnterococcusBacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalisTreatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycinNew perspectives of infections in cardiovascular diseaseFailure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studiesGentamicin dosing strategies for dogs with subclinical renal dysfunctionEnterococcal endocarditis: can we win the war?Laboratory detection of high-level aminoglycoside-aminocyclitol resistance in Enterococcus spp.The majority of a collection of U.S. endocarditis Enterococcus faecalis isolates obtained from 1974 to 2004 lack capsular genes and belong to diverse, non-hospital-associated lineages.Screening and treatment of infections caused by resistant enterococci.Therapy of enterococcal infections.The epidemiology of enterococci.Enterococcus faecalis infective endocarditis: focus on clinical aspects.Enterococcal endocarditis revisited.Therapy of patients with resistant bacterial infections.Combination of Ceftriaxone and Ampicillin for the Treatment of Enterococcal Endocarditis: A Qualitative Systematic Review.Spandra: a sustained release battlefield wound dressing.In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci.Group C streptococcal endocarditis: case report and review of the literature.Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards.Enterococcus, an emerging pathogen.Diagnosis and treatment of enterococcal endocarditis.What's New in the Treatment of Enterococcal Endocarditis?Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis.Endocarditis caused by resistant enterococcus: an overview.Effect of antibiotic treatment on vegetation size and complication rate in infective endocarditis.Issues in the Management of Endocarditis Caused by Resistant Gram-positive Organisms.Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database.Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used?Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.Outcome of Enterococcus faecalis infective endocarditis according to the length of antibiotic therapy: Preliminary data from a cohort of 78 patients.Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy.Prophylaxe der infektiösen EndokarditisAmpicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for TreatingEnterococcus faecalisInfective Endocarditis
P2860
Q24616875-3FAF5D2E-75CC-4F06-9739-A455B9B6AC12Q24645094-9DA0C30B-67BC-4E2B-B2D2-6AE86EBF443BQ28362159-FC3407B0-A2D7-4BFF-B786-6ADD508FCD96Q33587960-75B71D6C-EF65-4BF6-B39B-876BD0437B6DQ35540423-8E37CC0D-60F6-43FB-9A70-C2A7C2BD3122Q35540772-5A7DA880-78C0-4605-9AF8-46A83B25E05CQ35562787-74E0EC57-F2AB-4B91-A464-89E2A667F5A0Q35610638-7201F35B-2CEF-4C00-8BF8-4D4235A83761Q37157770-05F84726-A937-4D33-83F2-59202CCF3988Q37546149-E2AE4499-6BAC-4A7D-B97E-EE3C3ED80396Q37711795-70788353-D23F-4AC9-8F0F-A681ED68BC08Q37909576-9301EE2B-E5AA-4A69-BC38-A1586F020CCAQ37909583-8C81761E-B8DF-409E-B519-0FE6C154D804Q38145269-F6C9D636-F1F1-48F6-A1EF-51019684545BQ38539279-1F56C2BD-30E1-4302-BC16-D182C4165E0FQ38958218-F4EB0380-69C6-4262-BB03-BAF1693CD80FQ38976130-1E78911C-070F-42A0-ACBB-A7F954748302Q39705222-5B7BA6F8-1A70-426C-9651-4D693597D9D7Q39827844-862BFB1F-98BC-4EF0-A919-A5DC45C946FDQ39851582-2518A0D5-2594-4AF3-B649-2A156EEF568AQ39864434-90F80D4B-CC70-4FC1-8CF8-FF434AD390D4Q39874965-D21CA178-A29F-4457-82B7-4754C0E97B50Q40212219-413731BC-2061-479F-B1D5-46BBDF737F57Q40785841-1DA368C0-3428-445A-AB67-B0A3B78CB2D6Q40829731-0E60C1F2-A2E8-4F1B-8F10-52AE45725969Q41368979-D173317C-6F4E-4438-9CBF-AEF5A7458C4CQ42209166-B7B2D1BB-9139-4BAB-BBCD-89555AD53552Q42259672-FFBA52A2-4AF2-4012-9EFD-9C52A8E1B76EQ47315244-CA162452-64A9-4980-BFE7-43338FB028AFQ50791170-CAC93AF1-2E9D-4774-90F8-49ABBCED34E4Q51331712-00EE491A-3EB1-4658-BD6F-C9B735C9A6B5Q53319709-5B33D5FF-CC9C-487C-BBB0-577AEEAF4668Q53879693-2F697BA0-10F9-40E4-B4C1-3CCA5BA7DCB1Q54270189-695AE8AE-8671-479F-9733-3B63F4C80460Q54291144-740921EB-BFB7-4DC0-A7C9-D9F7C02548A1Q56656703-8F0871B5-A978-48AC-8AAF-19DFB7F77C05Q56794090-1314414D-FF35-4A83-AE47-8EC3BAAA5862
P2860
Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Treatment of streptomycin-susc ...... ant enterococcal endocarditis.
@en
Treatment of streptomycin-susc ...... ant enterococcal endocarditis.
@nl
type
label
Treatment of streptomycin-susc ...... ant enterococcal endocarditis.
@en
Treatment of streptomycin-susc ...... ant enterococcal endocarditis.
@nl
prefLabel
Treatment of streptomycin-susc ...... ant enterococcal endocarditis.
@en
Treatment of streptomycin-susc ...... ant enterococcal endocarditis.
@nl
P2093
P1476
Treatment of streptomycin-susc ...... ant enterococcal endocarditis.
@en
P2093
P304
P356
10.7326/0003-4819-100-6-816
P407
P577
1984-06-01T00:00:00Z